A Phase 1 Trial of X-396, a Novel ALK Inhibitor, in...

A Phase 1 Trial of X-396, a Novel ALK Inhibitor, in Patients With Advanced Solid Tumors

Horn, L., Blumenscheine, G., Wakelee, H.A., Arkenau, T.H., Dukart, G., Harrow, K., Liang, C., Gibbons, J.J., Lovly, C.M., Infante, J.R.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
90
Language:
english
Journal:
International Journal of Radiation Oncology*Biology*Physics
DOI:
10.1016/j.ijrobp.2014.08.251
Date:
November, 2014
File:
PDF, 82 KB
english, 2014
Conversion to is in progress
Conversion to is failed